Pain Management News

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a press release.

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was associated with reduced incidence of Parkinson’s disease, data show.

Integrating lifestyle care into low back pain management resulted in greater improvements in disability, weight loss and physical quality of life vs. just guideline-recommended care, a randomized study showed.

On this episode, hear the 2024 updates on COVID-19, long COVID and the latest developments in research in rheumatology. Hosted by Dr. Leonard Calabrese.

Over the past decade, I have been fortunate to have a platform on which to reflect about the varying dimensions of empathy as it applies to medical practice, and in particular its relevancy to the field of rheumatology.

Physician empathy has long been recommended — but not required — in the doctor-patient relationship.

Patients aged 65 years and older who use acetaminophen demonstrate greater risks for serious complications, including hypertension, chronic kidney disease and gastrointestinal bleeding, noted a study published in Arthritis Care & Research.

WASHINGTON — Pain in patients scheduled for total knee arthroplasty demonstrates no relation to physical activity, suggesting pain relief alone may not improve activity after the procedure, according to a speaker at ACR Convergence 2024.

The FDA has cleared an investigational new drug application for an epigenetic regulator to treat intractable pain due to idiopathic small fiber neuropathy, according to the manufacturer.